Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1 Oxacephalosporin
2. 1-oxacephalosporin
3. 6059 S
4. 6059-s
5. 6059s
6. Disodium Latamoxef
7. Disodium Moxalactam
8. Disodium, Moxalactam
9. Festamoxin
10. Lamoxactam
11. Latamoxef
12. Latamoxef, Disodium
13. Lilly 127935
14. Ly 127935
15. Ly-127935
16. Ly127935
17. Moxalactam
18. Moxalactam, Disodium
19. S 6059
20. S-6059
21. S6059
22. Shiomarin
1. Moxam
2. Latamoxef Sodium
3. Shiomarin
4. Latamoxef Disodium
5. Moxalactam Sodium
6. Disodium Latamoxef
7. 64953-12-4
8. Moxalactam Disodium Salt
9. Latamoxefum Dinatricum
10. Ly-127935
11. Moxalactam Disodium [usan]
12. 5apw73w3qz
13. Ly127935
14. Nsc-757107
15. 6059-s
16. Moxalactam Disodium (usan)
17. Dsstox_cid_25595
18. Dsstox_rid_80988
19. Dsstox_gsid_45595
20. N-((6r,7r)-2-carboxy-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-5-oxa-1-azabicyclo(4.2.0)oct-2-en-7-yl)-2-(p-hydroxyphenyl)malonamic Acid Disodium Salt
21. Shionogi 6059s
22. Antibiotic 6059-s
23. Moxalactam Sodium Salt
24. 5-oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-((carboxy(4-hydroxyphenyl)acetyl)amino)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, Disodium Salt
25. Unii-5apw73w3qz
26. Festamoxinly
27. Ly 127935
28. Moxalactam Disodium [usan:usp]
29. Prestwick_33
30. Shiomarin (tn)
31. Ncgc00017130-01
32. Einecs 265-288-4
33. Cas-64953-12-4
34. Antibiotic 6059s
35. Moxam (tn)
36. 6059s
37. Latamoxef Sodium (jp17)
38. Schembl49015
39. Spectrum1500418
40. Latamoxef Sodium [jan]
41. Chembl1200357
42. Dtxsid0045595
43. Hms502n11
44. Latamoxef Sodium [who-dd]
45. Hms1570d19
46. Hms1920p05
47. Hms2091h04
48. Latamoxef Disodium [mart.]
49. Moxalactam Disodium [vandf]
50. Tox21_110793
51. Ccg-40101
52. Mfcd03427565
53. Moxalactam Disodium Salt [mi]
54. Akos025310623
55. Tox21_110793_1
56. Nsc 757107
57. Moxalactam Disodium [orange Book]
58. Ncgc00178851-03
59. 6059 S
60. D02198
61. S-6059
62. A899855
63. Q27261755
64. (6r,7r)-7-[[(2r)-2-carboxy-2-(4-hydroxyphenyl)acetyl]amino]-7-methoxy-3-[[(1-methyl-1h-tetrazol-5-yl)thio]methyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid, Disodium Salt
65. (6r,7r)-7-[[2-carboxy(4-hydroxyphenyl)acetyl]amino]-7-methoxy-3-[[(1-methyl-1h-tetrazol-5-yl)thio]methyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid Disodium Salt
66. Disodium 7-((carboxylato(4-hydroxyphenyl)acetyl)amino)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-5-oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
| Molecular Weight | 564.4 g/mol |
|---|---|
| Molecular Formula | C20H18N6Na2O9S |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 13 |
| Rotatable Bond Count | 7 |
| Exact Mass | 564.06513591 g/mol |
| Monoisotopic Mass | 564.06513591 g/mol |
| Topological Polar Surface Area | 237 Ų |
| Heavy Atom Count | 38 |
| Formal Charge | 0 |
| Complexity | 947 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
A Moxalactam manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Moxalactam, including repackagers and relabelers. The FDA regulates Moxalactam manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Moxalactam API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Moxalactam manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Moxalactam supplier is an individual or a company that provides Moxalactam active pharmaceutical ingredient (API) or Moxalactam finished formulations upon request. The Moxalactam suppliers may include Moxalactam API manufacturers, exporters, distributors and traders.
click here to find a list of Moxalactam suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Moxalactam DMF (Drug Master File) is a document detailing the whole manufacturing process of Moxalactam active pharmaceutical ingredient (API) in detail. Different forms of Moxalactam DMFs exist exist since differing nations have different regulations, such as Moxalactam USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Moxalactam DMF submitted to regulatory agencies in the US is known as a USDMF. Moxalactam USDMF includes data on Moxalactam's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Moxalactam USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Moxalactam suppliers with USDMF on PharmaCompass.
Moxalactam Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Moxalactam GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Moxalactam GMP manufacturer or Moxalactam GMP API supplier for your needs.
A Moxalactam CoA (Certificate of Analysis) is a formal document that attests to Moxalactam's compliance with Moxalactam specifications and serves as a tool for batch-level quality control.
Moxalactam CoA mostly includes findings from lab analyses of a specific batch. For each Moxalactam CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Moxalactam may be tested according to a variety of international standards, such as European Pharmacopoeia (Moxalactam EP), Moxalactam JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Moxalactam USP).
LOOKING FOR A SUPPLIER?
